Personal information

No personal information available

Activities

Collapse all

Works (8)

Data from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-09-15 | Preprint
DOI: 10.1158/1078-0432.c.6717657.v2
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Data from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-09-15 | Preprint
DOI: 10.1158/1078-0432.c.6717657
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

Clinical Cancer Research
2023-09-15 | Journal article
DOI: 10.1158/1078-0432.CCR-23-1391
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Supplementary Table S1 from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-09-15 | Preprint
DOI: 10.1158/1078-0432.24146156.v1
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Supplementary Table S1 from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-09-15 | Preprint
DOI: 10.1158/1078-0432.24146156
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Data from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-06-28 | Preprint
DOI: 10.1158/1078-0432.c.6717657.v1
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Supplementary Table S1 from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-06-28 | Preprint
DOI: 10.1158/1078-0432.23593098
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref

Supplementary Table S1 from Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

2023-06-28 | Preprint
DOI: 10.1158/1078-0432.23593098.v1
Contributors: Lola A. Fashoyin-Aje; Craig Tendler; Bea Lavery; Serban Ghiorghiu; Brittany Gerald; Chitkala Kalidas; Nicole Richie; Kathleen Winson; Nicholas J.H. Warren; Tristen V. Tellman et al.
Source: check_circle
Crossref
How many people are using ORCID?